SCRIPTA THERAPEUTICS LIMITED

Active Oxford

Research and experimental development on biotechnology

5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
S

SCRIPTA THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 4 Oct 2024 Active Oxford, England 5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 24 Feb 2026 Next due 4 Jul 2026 2 months remaining
Confirmation Submitted 30 Oct 2025 Next due 17 Oct 2026 5 months remaining
Net assets £3M
Total assets £4M
Total Liabilities £658K
Charges None No charges registered

Contact & Details

Contact

Registered Address

Magdalen Centre Robert Robinson Avenue Oxford OX4 4GA England

Website

www.example.com

Full company profile for SCRIPTA THERAPEUTICS LIMITED (15999109), an active life sciences and medical technology company based in Oxford, England. Incorporated 4 Oct 2024. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2025–2025)

Cash in Bank

£2.42M

Net Assets

£2.86M

Total Liabilities

£657.50k

Turnover

N/A

Employees

5

Debt Ratio

19%

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (3)

Investor NameInvestor SinceParticipating Rounds
Investor 1Nov 2025Seed
Investor 2Nov 2025Seed
Investor 3Nov 2025Seed

Share Capital

Share Capital

Share allotments and capital structure

7 Allotments 7,443,036 Shares £9.60m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
20 Mar 2025751,879£1000k£1.33
20 Mar 2025751,879£1000k£1.33
17 Mar 202575,000£0.75£0
17 Mar 20252,857,139£3.80m£1.33
17 Mar 202575,000£0.75£0

Officers

Officers

3 active
Status
Barlow, RayDirectorBritishUnited Kingdom5825 Sept 2025Active
Mertens, Marianne, DrDirectorGermanGermany4225 Sept 2025Active
Peter Richard John HamleyDirectorBritishEngland594 Oct 2024Active

Shareholders

Shareholders (12)

Oxford Science Enterprises Plc
21.6%
939,849
Apollo Health Ventures Fund Scsp
21.6%
939,849

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Peter Richard John Hamley

British

Active
Notified 4 Oct 2024
Residence England
DOB June 1966
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Feb 2026AccountsAnnual accounts made up to 31 Dec 2025
22 Jan 2026AccountsAnnual accounts made up to 31 Oct 2025
30 Oct 2025MiscellaneousReplacement filing of SH01 - 20/03/25 Statement of Capital gbp 43.59018
30 Oct 2025Confirmation StatementConfirmation statement made on 3 Oct 2025 with updates
29 Oct 2025Persons With Significant ControlCessation of Peter Richard John Hamley as a person with significant control on 17 Mar 2025
24 Feb 2026 Accounts

Annual accounts made up to 31 Dec 2025

22 Jan 2026 Accounts

Annual accounts made up to 31 Oct 2025

30 Oct 2025 Miscellaneous

Replacement filing of SH01 - 20/03/25 Statement of Capital gbp 43.59018

30 Oct 2025 Confirmation Statement

Confirmation statement made on 3 Oct 2025 with updates

29 Oct 2025 Persons With Significant Control

Cessation of Peter Richard John Hamley as a person with significant control on 17 Mar 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

2 months ago on 24 Feb 2026

Annual accounts made up to 31 Oct 2025

3 months ago on 22 Jan 2026

Replacement filing of SH01 - 20/03/25 Statement of Capital gbp 43.59018

6 months ago on 30 Oct 2025

Confirmation statement made on 3 Oct 2025 with updates

6 months ago on 30 Oct 2025

Cessation of Peter Richard John Hamley as a person with significant control on 17 Mar 2025

6 months ago on 29 Oct 2025